USA flag logo/image

An Official Website of the United States Government

Development of a field-appropriate biosensor for detecting Mycobacterium…

Award Information

Agency:
Department of Defense
Branch:
N/A
Award ID:
Program Year/Program:
2013 / SBIR
Agency Tracking Number:
O2-1337
Solicitation Year:
2011
Solicitation Topic Code:
OSD11-H05
Solicitation Number:
2011.2
Small Business Information
NanoRETE, Inc
3815 Technology Blvd Suite 1050 Lansing, MI -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2013
Title: Development of a field-appropriate biosensor for detecting Mycobacterium tuberculosis infection
Agency: DOD
Contract: FA8650-13-C-6392
Award Amount: $750,000.00
 

Abstract:

nanoRETE is a developing a nanoparticle-based biosensor technology platform that has the ability for real-time detection of pathogens. Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis (Mtb) that primarily affects the lungs. In Phase I research, nanoRETE demonstrated proof-of-concept of an electrochemical nano-bead biosensor for measuring plasma cytokine and chemokine concentrations that have been identified as biomarkers of Mtb infection. In Phase II research, an optimized electrochemical multiplex assay for rapid TB detection will be developed using a prototype biosensor cartridge. The prototype will then be tested with clinical samples. Finally, a fully-integrated"sample in-results out"TB screening device will be designed and experimental plans for Phase III laid out.

Principal Investigator:

Houng-Yau Mei
COO
(734) 649-2486
hmei@nanorete.com

Business Contact:

Fred Beyerlein
CEO
(734) 223-2591
fbeyerlein@nanorete.com
Small Business Information at Submission:

NanoRETE, Inc
3815 Technology Blvd Suite 1050 Lansing, MI -

EIN/Tax ID: 800712341
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No